Company Filing History:

15 out of 4,455

Pfizer Corporation

patents

2 out of 118

Osi Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2001-2010

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7790902 - Isothiazole derivatives useful as anticancer agents (2010-09-07),

2. 7462600 - Macrolides (2008-12-09),

3. 7405218 - Isothiazole derivatives useful as anticancer agents (2008-07-29),

4. 7030242 - Selective inhibition of aggrecanase in osteoarthritis treatment (2006-04-18),

5. 6919332 - N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors (2005-07-19),

6. 6916807 - Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors (2005-07-12),

7. 6900201 - N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors (2005-05-31),

8. 6841671 - Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors (2005-01-11),

9. 6706723 - Pyrimidine-2,4,6-trione metalloproteinase inhibitors (2004-03-16),

10. 6608104 - Gem substituted hydroxamic acids (2003-08-19),

11. 6599890 - Arylsulfonyl hydroxamic acid derivatives (2003-07-29),

12. 6548526 - Isothiazole derivatives useful as anticancer agents (2003-04-15),

13. 6380214 - Heterocyclic derivatives useful as anticancer agents (2002-04-30),

14. 6329397 - Hydroxy pipecolate hydroxamic acid derivatives (2001-12-11),

15. 6235764 - Isothiazole derivatives useful as anticancer agents (2001-05-22),

Title: The Innovative Journey of Mark Carl Noe

Introduction: Mark Carl Noe is an accomplished inventor based in Mystic, CT, USA, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 15 patents, he has dedicated his career to developing compounds that can advance medical treatments.

Latest Patents: Mark's latest innovations include his work on isothiazole derivatives, recognized for their potential as anticancer agents. These compounds are part of a broader category of macrolides, which are beneficial for their antibacterial and antiprotozoal properties in humans and animals. His patents cover not only the compounds themselves but also the methods of preparing these compounds and their applications in treating diseases.

Career Highlights: Mark has built a prolific career in the pharmaceutical industry, having worked with eminent companies such as Pfizer Corporation and Osi Pharmaceuticals. His expertise has contributed to the development of important therapeutic agents, enhancing the landscape of modern medicine through innovative research and solutions.

Collaborations: Throughout his career, Mark has collaborated with talented professionals, including Thomas George Gant and Eric R. Larson. These partnerships have played a crucial role in enriching his research and expanding the impact of his inventions across various therapeutic domains.

Conclusion: Mark Carl Noe's inventive spirit and dedication to innovation continue to drive advancements in the pharmaceutical field. With his extensive patent portfolio and collaborative efforts, he actively contributes to healthcare solutions that hold promise for better treatment options in the future. His work exemplifies the vital role of inventors in transforming ideas into tangible advancements that benefit society.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.